MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma
2016 ◽
Vol 81
◽
pp. 195-207
◽
2018 ◽
Vol 37
(1)
◽
Keyword(s):
2018 ◽
Vol 21
(7)
◽
pp. 924-932
◽
Keyword(s):
2021 ◽
Vol 25
(2)
◽
pp. 131-139
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 130
(2)
◽
pp. 319-327
◽